How a Mesothelioma Patient Stays in the Game Cedars-Sinai Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close Los Angeles, 25 September 2020 06:00 AM America/Los_Angeles How a Mesothelioma Patient Stays in the Game Mesothelioma has not stopped Martin Snyder from living--and enjoying--his life. Photo by Cedars-Sinai. Rare Cancer Doesn t Stop Los Angeles Psychotherapist from Hitting the Tennis Court It started on the tennis court, in 2016. A lunge for the ball, an awkward fall, and then sore ribs with subsequent backhands. At least that's what Martin Snyder thought was the cause of his pain. He was wrong. An X-ray and further imaging over the ensuing weeks revealed that the slim and fit psychotherapist, then 73, had mesothelioma, a rare cancer usually caused by asbestos exposure. Looking back on that period of diagnostic tests and doctors' appointments, Snyder recalls telltale cancer signs: loss of appetite and significant weight (40 pounds). He wanted to share his story for Mesothelioma Awareness Day, Sept. 26, to let others know that the symptoms he experienced should be reviewed by a physician. "I lost energy on the tennis court, where I typically played two to three hours at a time," Snyder said. "I usually could run the court like a teenager, playing with guys in their 20s and 30s. They asked how I could play that way in my 70s." Fatigue is one of several symptoms associated with mesothelioma, a cancer that commonly starts in cells in the linings of the chest or abdomen. Pleural mesothelioma, accounting for 80%-90% off all cases, affects the pleura, which covers the lungs and the space surrounding the lungs. Making up 10%-15% of cases, malignant peritoneal mesothelioma affects the peritoneum, which lines the inside of the abdomen and covers many of the organs there. Additional symptoms include chest or abdominal pain, shortness of breath, fluid buildup, fever, night sweats and weight loss, according to the American Cancer Society. The average time for symptoms to develop is 35-40 years after asbestos exposure. " Patients like Dr. Snyder who respond to and tolerate treatment can enjoy a good quality of life, and he has. He's continued to play tennis, travel and maintain a positive attitude, even as he has faced fresh health challenges. Jeremy Lorber, MD„ Mesothelioma is rare in the United States and usually is lethal. About 3,000 new cases of the disease are diagnosed each year. Typical life expectancy is up to two years after diagnosis, although that can improve with treatment, said Jeremy Lorber, MD, an oncologist at Cedars-Sinai Tower Hematology Oncology Medical Group, who is treating Snyder. Mesothelioma begins when asbestos fibers damage lung cells and result in scar tissue and/or lung cancer, according to the cancer society. Peritoneal mesothelioma forms in the abdomen when inhaled asbestos fibers are coughed up and then swallowed. Rarely, a mutation, or change, in the gene called BAP1 – which is associated with the BRCA1 gene mutation – can be passed down in families and has been linked to mesothelioma. "Most mesothelioma cases do not carry this mutation," Lorber said. "But it did cause Dr. Snyder's peritoneal mesothelioma." The psychotherapist also was treated for prostate cancer at age 66, a disease sometimes associated with the BRCA1 gene mutation. His brother also had BRCA1-associated cancers. Snyder's case had other twists and turns. Following his 2016 diagnosis, he underwent surgery to remove the cancer – typically not an option for mesothelioma patients – followed by standard chemotherapy treatments. He was disease-free for three years. "Patients like Dr. Snyder who respond to and tolerate treatment can enjoy a good quality of life, and he has," Lorber said. "He's continued to play tennis, travel and maintain a positive attitude, even as he has faced fresh health challenges." In 2019, a CT scan revealed that the mesothelioma had returned. Snyder underwent surgery again, followed by chemotherapy and immunotherapy. Earlier this year, a scan revealed that the cancer had spread. He currently is enrolled in a large precision-medicine clinical trial called the Targeted Agent and Profiling Utilization Registry, or TAPUR trial. Treatment is based on a patient's gene mutation, Lorber said. Snyder is tolerating his treatment well and is stable, he added. Snyder attributes his resilience and strong quality of life to his healthful lifestyle, involvement with his doctors in his treatments and an unwavering positive attitude, which he recommends his fellow cancer travelers embrace. He also suggests that patients research their cancer, as new information and treatments continue to emerge. "I'm a rare bird – I have a rare type of a rare cancer," Snyder said. "I inherited a cancer gene mutation from my mother, but she also gave me my handsome genes! I refuse to feel sorry for myself, and I continue to work, hit the tennis court, hike and work out. When I do die, it will be with a smile on my face." Read about lung cancer screening on the Cedars-Sinai blog: Should I Get a Lung Cancer Screening? Related Stories RSS feed - Related Stories (opens in new window) View all headlines - Related Stories Cancer Patient Sails Again A Tumor on Her Spine Kept Jeannea Jordan Ashore but Her Cedars-Sinai Neurosurgeon Got Her Back on Her Boat September 19, 2022 06:00 AM America/Los_Angeles Jeannea Jordan, who turns 80 in October, is a local sailing pioneer who began racing and cruising her 30-foot sailboat 25 years ago when few women were part of the sport. When a tumor on her spine … Read more Share this release (opens in dialog) Study Active Surveillance an Effective Option for Thyroid Cancer Research Published in JAMA Oncology Determines Many Low-Risk Thyroid Cancers Can Be as Effectively Managed With Monitoring as With Surgery September 15, 2022 08:01 AM America/Los_Angeles A novel clinical trial from Cedars-Sinai Cancer shows that active surveillance is an effective treatment for many low-risk thyroid cancer patients. The study, published in JAMA Oncology, also showed … Read more Share this release (opens in dialog) Study Patients Prefer Stool Test to Colonoscopy Cedars-Sinai Investigators Find Nearly Three-Quarters of Study Participants Prefer Less-Invasive Option for Colorectal Cancer Screening September 12, 2022 10:00 AM America/Los_Angeles Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study.Unlike … Read more Share this release (opens in dialog) Show previous items Show next items Contact the Media Team Email: [email protected] Contact Share this release How a Mesothelioma Patient Stays in the Game Share on: Twitter Share on: Facebook Share on: LinkedIn Search Our Newsroom Social media Visit our Facebook page (opens in new window) Follow us on Twitter (opens in new window) Visit our Youtube profile (opens in new window) (opens in new window) Latest news 07 Oct 2022 - HealthDay: Black Women Less Likely to Get Laparoscopic Fibroid Surgeries 07 Oct 2022 - Faculty Publications: Sept. 29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Booster? Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics 04 Oct 2022 - Cedars-Sinai Showcases Hispanic and Latinx Art Newsroom Home